BayWa’s May 26 Report to Gauge Credibility After €1.7B Deal Collapse and Debt Write-Down Threat

BayWa's €1.7B renewable energy sale fails after US law cuts subsidies, forcing €1B debt haircut. T&G Global sale underway; restructuring hinges on autumn 2026 deadlines.

The €1.7 billion rescue sale that was supposed to anchor BayWa’s restructuring has collapsed, leaving the Munich-based agricultural group scrambling for a new plan that, by all indications, will force creditors to swallow billions in losses. The first real check on whether the company can stay on course arrives on 26 May, when it publishes its quarterly update for the first three months of 2026.

The now-defunct centrepiece of the original recovery strategy was the sale of a 51 percent stake in BayWa r.e., the group’s renewable energy division. That transaction was torpedoed by the “One Big Beautiful Bill Act” signed by US President Donald Trump, which strips federal subsidies for wind and solar projects and renders the unit effectively unsaleable under current market conditions. The resulting impairment is estimated to run into the high nine figures, potentially exceeding €1 billion. A replacement concept is due by mid-2026, but it will almost certainly require a debt haircut of roughly €1 billion — meaning lenders must accept a significant reduction in what they are owed.

The cooperative banks that form the backbone of BayWa’s financing have already started provisioning. In their 2024 annual accounts, they wrote down 60 percent of a €220 million Schuldschein loan. Stefan Müller, president of the Bavarian cooperative association, confirmed at a press conference that further write-downs had been recommended — in the worst case, a complete write-off in the hundreds of millions of euros.

Amid that financial pressure, BayWa is pushing ahead with the sale of its New Zealand fruit subsidiary T&G Global, where Goldman Sachs has been running a bid process since March 2026. The 74 percent stake in T&G, which markets apple brands such as Envy and Jazz across more than 60 countries and generated US$1.3 billion in revenue last year, is expected to fetch around €300 million. Ag-focused private equity firms including Roc Partners, Paine Schwartz and Hancock are seen as potential buyers. Yet the deal is complicated by Hong Kong’s Joy Wing Mau Group, which holds nearly 20 percent of T&G and can block a majority takeover.

For the broader restructuring to hold, BayWa must clear three hurdles by autumn 2026: deliver an audited full-year 2025 financial statement (not expected until the fourth quarter of 2026), secure bank consent to extend the standstill agreement with DZ Bank and UniCredit, and complete the T&G sale. If any one of these conditions fails, the StaRUG restructuring plan finalised in May 2025 collapses.

Operationally, the group has set an aggressive shrinkage strategy: focus on four core business areas, cut roughly 1,300 jobs, and reduce annual revenue to about €10 billion by 2028. No guidance has been issued for 2026. The adjusted EBITDA target for 2027 stands at around €140 million. A bright spot, according to board member Marlen Wienert, is that liquidity has reached its highest level since the crisis began — a claim the quarterly report will either confirm or refute.

The legal front is equally fraught. Munich prosecutors are investigating former chief executives Klaus Josef Lutz and Marcus Pöllinger on suspicion of breach of trust and false representation in the 2023 annual accounts. Both men maintain their innocence. The corporate governance enforcer BaFin has already criticised BayWa for omitting material details about a €1 billion loan and refinancing risks on a €500 million bond in the 2023 management report — a rebuke that has opened the door to shareholder lawsuits filed by the law firm TILP on behalf of investors who bought shares between January 2022 and January 2026. Meanwhile, the audit watchdog Apas is examining whether auditor PricewaterhouseCoopers should have flagged going-concern risks when it issued an unqualified opinion for the 2023 accounts.

The stock has taken a beating. At around €12.55, it has lost roughly a third of its value over the past twelve months, and the 52-week high of €21.50 is more than 40 percent away. With a 30-day annualised volatility above 90 percent, the equity reflects the extreme uncertainty hanging over the company.

The 26 May quarterly will be the first concrete evidence of whether cost cuts are taking hold and liquidity is actually improving — months ahead of the decisive autumn negotiations with DZ Bank and UniCredit. For investors and creditors alike, it is the first hard data point after a period dominated by broken promises and mounting legal bills.